Scribe Therapeutics Statistics
Total Valuation
SCTX has a market cap or net worth of $531.03 million. The enterprise value is $531.29 million.
| Market Cap | 531.03M |
| Enterprise Value | 531.29M |
Important Dates
The last earnings date was Wednesday, September 2, 2026, after market close.
| Earnings Date | Sep 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCTX has 18.93 million shares outstanding.
| Current Share Class | 18.93M |
| Shares Outstanding | 18.93M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 8.80% |
| Owned by Institutions (%) | 4.38% |
| Float | 6.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.95 |
| Forward PS | 48.66 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.57
| Current Ratio | 0.57 |
| Quick Ratio | 0.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 147.84% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $406,122 |
| Profits Per Employee | -$393,951 |
| Employee Count | 82 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -334,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.53 |
| Average Volume (20 Days) | 339,767 |
Short Selling Information
The latest short interest is 778,191, so 4.11% of the outstanding shares have been sold short.
| Short Interest | 778,191 |
| Short Previous Month | 284,711 |
| Short % of Shares Out | 4.11% |
| Short % of Float | 11.30% |
| Short Ratio (days to cover) | 3.61 |
Income Statement
In the last 12 months, SCTX had revenue of $33.30 million and -$32.30 million in losses. Loss per share was -$13.18.
| Revenue | 33.30M |
| Gross Profit | -17.75M |
| Operating Income | -30.71M |
| Pretax Income | -32.64M |
| Net Income | -32.30M |
| EBITDA | -27.82M |
| EBIT | -30.71M |
| Loss Per Share | -$13.18 |
Balance Sheet
The company has $43.01 million in cash and $43.27 million in debt, with a net cash position of -$261,000 or -$0.01 per share.
| Cash & Cash Equivalents | 43.01M |
| Total Debt | 43.27M |
| Net Cash | -261,000 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | -44.49M |
| Book Value Per Share | -66.33 |
| Working Capital | -33.59M |
Cash Flow
In the last 12 months, operating cash flow was -$37.85 million and capital expenditures -$368,000, giving a free cash flow of -$38.22 million.
| Operating Cash Flow | -37.85M |
| Capital Expenditures | -368,000 |
| Depreciation & Amortization | 2.89M |
| Net Borrowing | n/a |
| Free Cash Flow | -38.22M |
| FCF Per Share | -$2.02 |
Margins
Gross margin is -53.29%, with operating and profit margins of -92.20% and -97.00%.
| Gross Margin | -53.29% |
| Operating Margin | -92.20% |
| Pretax Margin | -98.01% |
| Profit Margin | -97.00% |
| EBITDA Margin | -83.54% |
| EBIT Margin | -92.20% |
| FCF Margin | n/a |
Dividends & Yields
SCTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -6.08% |
| FCF Yield | -7.20% |
Analyst Forecast
The average price target for SCTX is $57.00, which is 103.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $57.00 |
| Price Target Difference | 103.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -48.48% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCTX has an Altman Z-Score of -6.26. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.26 |
| Piotroski F-Score | n/a |